Fellowship · Chapel Hill, NC
Sponsored by University of North Carolina Hospitals
Chronic kidney disease and the global public health agenda: an international consensus.
Nature reviews. Nephrology · 2024 · 985 citations · Prabir Roy-Chaudhury
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
The New England journal of medicine · 2025 · 232 citations · Amy K. Mottl
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Kidney international · 2021 · 757 citations · Keisha L. Gibson, Carla Nester
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2021 · 476 citations · Keisha L. Gibson
Dialysis for Chronic Kidney Failure: A Review.
JAMA · 2024 · 144 citations · Jennifer E. Flythe
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · 101 citations ·
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
The New England journal of medicine · 2023 · 195 citations · Ronald J. Falk
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney international · 2023 · 103 citations · Jennifer E. Flythe